Mode
Text Size
Log in / Sign up

Pilot trial finds acute taVNS effects on blood pressure differ by stimulation site and hypertension statusCan a gentle ear stimulation lower blood pressure? Early results show it depends

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Interpret acute taVNS cardiovascular effects as preliminary, site-specific, and differing by hypertension status.

This randomized crossover pilot trial evaluated the acute effects of transcutaneous auricular vagus nerve stimulation (taVNS) on blood pressure and cardiac autonomic modulation in 14 hypertensive and 14 healthy participants. Each participant received two taVNS sessions (tragus and cymba conchae) in randomized order one week apart, with systolic BP (SBP), diastolic BP (DBP), and heart rate variability (HRV) parameters assessed at baseline, during stimulation, and post-stimulation.

Analysis revealed significant group × time × stimulation site interactions for both SBP (χ² = 19.0, p = 0.001) and DBP (χ² = 10.0, p = 0.038). Cymba conchae stimulation reduced BP in healthy individuals, while no meaningful BP changes were observed in hypertensive participants with this site. Tragus stimulation reduced diastolic BP only in the hypertensive group. Significant interactions were also detected for normalized spectral HRV components and sample entropy (p < 0.05), though responses were modest and not consistently indicative of enhanced parasympathetic modulation.

Safety and tolerability data were not reported. Key limitations include the pilot nature of the study, single-session assessment, and limited clinical impact after a single session. The authors note short-term stimulation may be insufficient to overcome impaired autonomic regulation in hypertension. These findings highlight the need for repeated or longer stimulation protocols in future clinical trials to determine if taVNS could have therapeutic potential for blood pressure management.

Imagine if lowering your blood pressure was as simple as a gentle zap to your ear. That's the idea behind a new pilot study that tested a non-invasive technique called transcutaneous auricular vagus nerve stimulation (taVNS). Researchers wanted to see if stimulating different parts of the outer ear could have an immediate effect on blood pressure and heart rate patterns in 14 people with high blood pressure and 14 healthy people.

The study found that the body's response depends on both where you stimulate and who you are. When healthy people received stimulation on a specific part of the ear called the cymba conchae, their blood pressure went down a bit. But for people with high blood pressure, that same spot didn't do much. Instead, they saw a small drop in one part of their blood pressure when a different spot, the tragus, was stimulated. The researchers also noted changes in heart rate variability, a measure of the nervous system's influence on the heart, but these signals were modest and not clearly tied to relaxation.

It's important to remember this was a very small, early-stage pilot study. The effects were measured during and right after a single session, so we don't know if they last or what happens with repeated use. The authors themselves note that a short session might not be enough to overcome the body's impaired regulation in chronic high blood pressure. This research is a first step, highlighting that future studies need to test longer or repeated stimulation to see if it could ever have a real clinical impact.

What this means for you:
A single ear stimulation session shows mixed, small blood pressure effects that differ between healthy and hypertensive people.

Study Details

Study typeRct
EvidenceLevel 2
PublishedApr 2026
View Original Abstract ↓
BACKGROUND: and PurposeTranscutaneous auricular vagus nerve stimulation (taVNS) has emerged as a promising noninvasive strategy to modulate autonomic function and reduce blood pressure (BP). However, whether the stimulation site influences acute cardiovascular responses remains unclear. OBJECTIVE: To compare the acute effects of taVNS applied to the tragus and cymba conchae on BP and cardiac autonomic modulation in hypertensive and healthy individuals. METHODS: This pilot randomized crossover clinical trial included 14 hypertensive and 14 healthy participants who underwent two taVNS sessions (tragus and cymba conchae) in randomized order, one week apart. Sessions lasted 30 min and delivered a sinusoidal current (30 Hz, 500 ms pulse width), with intensity adjusted to the individual sensory threshold. Systolic BP (SBP), diastolic BP (DBP), and heart rate variability (HRV) parameters were assessed at baseline, during stimulation, and post-stimulation. Generalized estimating equations were used for analysis. RESULTS: A significant group × time × stimulation site interaction was observed for SBP (χ = 19.0, p = 0.001) and DBP (χ = 10.0, p = 0.038). Cymba conche stimulation reduced BP in healthy individuals, whereas no meaningful BP changes were observed in hypertensive participants. Tragus stimulation reduced diastolic BP only in the hypertensive group. Significant interactions were also detected for normalized spectral HRV components and sample entropy (p < 0.05), though autonomic responses were modest and not consistently indicative of enhanced parasympathetic modulation. DISCUSSION: Acute taVNS induces site- and group-dependent cardiovascular responses, with limited clinical impact after a single session. These findings suggest that short-term stimulation may be insufficient to overcome impaired autonomic regulation in hypertension and highlight the need for repeated or longer stimulation protocols in future clinical trials.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.